The international society of gynecological cancer’s (IGCS) biennial meeting was held in Kyoto, Japan from September 14 to 16, 2018. As the only product of a Chinese company, FRD™ was the center of many in-depth technical exchanges with experts from all over the world. This is the second time to receive such success as we attended IGCS in Lisbon in 2016. There FRD™ was presented with high praise from the doctors in attendance. More than 200 articles on gynecological tumors were reported and exhibited at this year’s IGCS Conference. Among them, papers on FRD™screening for HPV-positive patients by doctors in Beijing Multi-Center Research and on FRD™ detection for high grade cervical lesions in Foshan First People’s Hospital were presented.